#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Laryngeal squamous cell carcinoma B-cell lymphoma refractory Acute hepatic failure Central nervous system neoplasm Congenital absence of bile ducts Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Congenital disorder of glycosylation Mucopolysaccharidosis III Arrhythmia Glioblastoma multiforme Acromegaly Neoplasm Follicular lymphoma stage III Glioblastoma Mixed-type liposarcoma More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Life with Disease Isodicentric chromosome 15 syndrome – Trials in Disease Haemophagocytic lymphohistiocytosis – Trials in Disease Antithrombin III deficiency – Life with Disease Ornithine transcarbamoylase deficiency – Treatment Leiomyosarcoma metastatic – Life with Disease Synovial sarcoma – Trials in Disease Ewing’s sarcoma metastatic – Life with Disease Encephalitis autoimmune – Life with Disease Glycogen storage disease type II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vatiquinone Milnacipran Hydrochloride Cefoxitin INCB123667 ALE1 Bi 1015550 GSKVX000000025896 Clofarabine Quinidine Sulfate Dinutuximab Beta Suxamethonium Chloride Gsk3915393 Ferric Carboxymaltose Jnj-77242113 FRUQUINTINIB Flecainide Acetate Mometasone D,L-Lysine Acetylsalicylate Nafarelin Ixekizumab More therapies…

    Learn about Your Condition

    Alcoholism Diabetes insipidus Bone metabolism disorder Ependymoma malignant Hydrocephalus Neurofibromatosis Cough Rectal cancer Lyme disease Cutaneous lupus erythematosus Glioblastoma multiforme Corneal graft rejection Generalised anxiety disorder Malignant neoplasm of choroid Endocarditis enterococcal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Cetuximab
    • Trastuzumab
    Austria Belgium France Germany Greece Hungary +8

  • Study of ivosidenib in adults with advanced or metastatic chondrosarcoma with IDH1 mutation who are untreated or have had one prior treatment

    Recruiting

    3 1
    Investigated Diseases:
    • Chondrosarcoma
    Investigated Drugs:
    • Ivosidenib
    Belgium Denmark France Germany Italy The Netherlands +1

  • Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Belantamab Mafodotin
    • Bortezomib
    • Daratumumab
    Belgium Czechia France Germany Greece Italy +3

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Breast cancer metastatic
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    • Calcium Folinate
    Belgium France Germany Italy Spain

  • Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • H2-Receptor Antagonists
    Austria Belgium Czechia Denmark Finland France +9

  • Long-Term Safety Study of BCMACP03, BCN-CP01, and 19CP02 for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, CLL, SLL, or Multiple Myeloma

    Recruiting

    3 1 1
    Investigated Drugs:
    • 19Cp02
    • Bcmacp03
    Belgium Finland The Netherlands Spain

  • Study on the Safety and Effects of Lutetium (177Lu) rhPSMA-10.1 Injection in Men with Advanced Prostate Cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • 177Lu-Rhpsma-10.1
    Belgium Germany The Netherlands

  • Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

    Recruiting

    2 1
    Investigated Diseases:
    • Indolent systemic mastocytosis
    Investigated Drugs:
    • 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
    Belgium Bulgaria France Germany Italy The Netherlands +3

  • Study on Sarilumab and Etanercept for Rheumatoid Arthritis in Patients Not Responding to csDMARD Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    • Sarilumab
    Belgium Germany Italy The Netherlands Portugal Spain

  • Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nipocalimab
    Belgium Czechia Denmark France Germany Italy +3
Previous Page
1 … 18 19 20 21 22 … 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!